Those with HPLC but not IN detectable albuminuria had higher BP, worse
glycaemic control and more vascular events ( p < 0.05 for all) but received fewer vascular risk
reduction treatments.
Those with HPLC but not IN detectable albuminuria had higher BP,
worse
glycaemic control and more vascular events ( p < 0.05 for all) but received fewer vascular risk
reduction treatments.